MyHep All Tablet (Sofosbuvir + Velpatasvir)

In stock
100% of 100

Sofosbuvir + Velpatasvir Tablet is a combination medication used for the treatment of chronic hepatitis C virus (HCV) infection. This combination therapy contains two active ingredients: sofosbuvir and velpatasvir. MyHep All and Epclusa is the brand name for the combination medication containing sofosbuvir and velpatasvir.

Read More

MyHep All Tablet (Sofosbuvir (400mg) + Velpatasvir (100mg))

PackageQTYPriceAdd To Cart
28 Tablet/s (1 Bottle) $583.33
56 Tablet/s (2 Bottles) $1,170.00
84 Tablet/s (3 Bottles) $1,755.00

Introduction of MyHep All Tablet (Sofosbuvir + Velpatasvir)

Sofosbuvir + Velpatasvir Tablet is a combination medication used for the treatment of chronic hepatitis C virus (HCV) infection. This combination therapy contains two active ingredients: sofosbuvir and velpatasvir. Sofosbuvir is a direct-acting antiviral (DAA) agent that targets the HCV RNA polymerase, while velpatasvir is an inhibitor of the HCV NS5A protein. When used together, these drugs work synergistically to inhibit viral replication and reduce the viral load in the body. Epclusa is the brand name for the combination medication containing sofosbuvir and velpatasvir. It is widely recognized as an effective treatment for chronic hepatitis C virus (HCV) infection. Epclusa is prescribed as a once-daily oral therapy and is known for its high efficacy and tolerability. It has become a cornerstone of HCV treatment due to its broad genotypic coverage and favorable clinical outcomes.

Dosage Information

The recommended dosage of Sofosbuvir + Velpatasvir Tablet is one tablet taken orally once daily, with or without food. The duration of treatment may vary depending on the specific HCV genotype and the presence of liver cirrhosis. It is important to follow the prescribed dosage and duration of treatment as directed by your healthcare provider. Sofosbuvir + Velpatasvir Tablet is available in fixed-dose combination tablets, simplifying the dosing regimen and enhancing patient adherence.

MyHep All Tablet (Sofosbuvir + Velpatasvir) Uses

Sofosbuvir + Velpatasvir Tablet is primarily indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is effective against all HCV genotypes, including genotypes 1-6. This combination therapy is particularly valuable for patients with compensated liver disease, decompensated cirrhosis, and those with coexisting HIV infection. Sofosbuvir + Velpatasvir Tablet has demonstrated high rates of sustained virologic response (SVR), indicating a cure for hepatitis C infection. It has also been associated with improved liver function and reduced risk of complications such as liver cirrhosis and hepatocellular carcinoma.

Sofosbuvir+Velpatasvir Tablet online: You can conveniently purchase Sofosbuvir+Velpatasvir Tablets online at our website. We offer a user-friendly platform where you can browse and order your medication from the comfort of your own home. Our website provides detailed information about the product, including dosage, usage, and safety precautions. We prioritize customer privacy and ensure secure transactions for a seamless online shopping experience.

You can check the Sofosbuvir+Velpatasvir Tablets availability at our website: To verify the availability of Sofosbuvir+Velpatasvir Tablets, you can visit our website. We maintain a regularly updated inventory to ensure that the medication is in stock and readily accessible to our customers. Our website offers real-time information on product availability, allowing you to make informed decisions regarding your treatment.

Sofosbuvir+Velpatasvir Tablet alternatives:
While Sofosbuvir+Velpatasvir Tablet is a highly effective treatment option for chronic hepatitis C virus (HCV) infection, there may be alternative medications available depending on individual circumstances. It is essential to consult with your healthcare provider to determine the most suitable treatment regimen for your specific needs. Some of the alternative medications for HCV treatment include ledipasvir/sofosbuvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir. Your healthcare provider will consider various factors, such as HCV genotype, prior treatment history, and any underlying medical conditions, to guide you toward the most appropriate treatment choice.

MyHep All Tablet (Sofosbuvir + Velpatasvir) Side Effects

  • Common side effects of Sofosbuvir + Velpatasvir Tablet include headache, fatigue, nausea, diarrhea, and insomnia.
  • Some patients may experience allergic reactions, such as rash, itching, swelling, or difficulty breathing. Seek immediate medical attention if any signs of an allergic reaction occur.
  • Sofosbuvir + Velpatasvir Tablet/Epclusa may cause a decrease in hemoglobin levels, leading to anemia. Regular blood tests are recommended during treatment to monitor the hemoglobin levels.
  • In rare cases, this medication may cause serious bradycardia (slow heart rate), especially when co-administered with amiodarone. It is essential to report any symptoms of dizziness, fainting, or irregular heartbeat to your healthcare provider.
  • Hepatitis B reactivation has been reported in patients co-infected with HCV and HBV. Close monitoring is necessary for individuals with both infections during and after treatment.
  • In some instances, Sofosbuvir + Velpatasvir Tablet may lead to elevated levels of liver enzymes, indicating liver injury. Regular liver function tests are recommended throughout the treatment period.
  • The use of this medication may result in a decrease in kidney function, particularly in patients with pre-existing kidney disease. Monitoring kidney function is important during treatment.
  • Other potential side effects include muscle pain, joint pain, depression, and changes in taste sensation. Consult your healthcare provider if these or any other unusual symptoms occur.

MyHep All Tablet (Sofosbuvir + Velpatasvir) Precautions

  • Before initiating treatment with Sofosbuvir + Velpatasvir Tablet, inform your healthcare provider about any known allergies to the medication or its components.
  • It is crucial to disclose your complete medical history, including any liver problems, kidney disease, or other significant health conditions, to ensure the safe use of this medication.
  • Sofosbuvir + Velpatasvir Tablet should be used with caution in patients with moderate to severe liver impairment, as dosage adjustments may be necessary.
  • Pregnant women or those planning to become pregnant should consult their healthcare provider regarding the potential risks and benefits of using this medication.
  • Breastfeeding women should also seek medical advice before starting treatment, as it is unknown whether the drug passes into breast milk.

MyHep All Tablet (Sofosbuvir + Velpatasvir) Drug Interactions

  • Sofosbuvir + Velpatasvir Tablet/Epclusa may interact with certain medications, such as rifampin, carbamazepine, phenytoin, and St. John's Wort, reducing the effectiveness of the combination therapy. It is essential to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.
  • Co-administration of Sofosbuvir + Velpatasvir Tablet with certain antiviral agents, such as atazanavir, darunavir, or lopinavir/ritonavir, may require dosage adjustments to ensure proper treatment outcomes.
  • The concomitant use of amiodarone with Sofosbuvir + Velpatasvir Tablet may increase the risk of serious cardiac arrhythmias. Close monitoring of heart function is recommended in such cases.


Q: Can Sofosbuvir + Velpatasvir Tablet/Epclusa be taken with food?

A: Yes, Sofosbuvir + Velpatasvir Tablet can be taken with or without food. It does not significantly affect the absorption or efficacy of the medication.

Q: What should I do if I miss a dose of Sofosbuvir + Velpatasvir Tablet?

A: If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed one.

Q: Can Sofosbuvir + Velpatasvir Tablet be used in pediatric patients?

A: The safety and efficacy of Sofosbuvir + Velpatasvir Tablet have not been established in pediatric patients. It is primarily indicated for use in adults aged 18 years and older.

Q: Are there any specific monitoring requirements during treatment with Sofosbuvir + Velpatasvir Tablet?

A: Regular monitoring of liver function, including liver enzymes, is recommended during treatment with Sofosbuvir + Velpatasvir Tablet. It is also important to monitor hemoglobin levels and kidney function in certain patients.

Q: Can I consume alcohol while taking Sofosbuvir + Velpatasvir Tablet?

A: It is advisable to avoid or limit alcohol consumption during treatment with Sofosbuvir + Velpatasvir Tablet. Alcohol can increase the risk of liver damage and may interfere with the effectiveness of the medication.

Write Your Own Review
You're reviewing:MyHep All Tablet (Sofosbuvir + Velpatasvir)
Your Rating
More Information
Manufacturer:A. Menarini India Pvt Ltdine HCL)
Equivalent Brand:Epclusa
Generic Search:Sofosbuvir + Velpatasvir
Strength:400mg + 100mg